Omnicell Inc
NASDAQ:OMCL
Intrinsic Value
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. [ Read More ]
The intrinsic value of one OMCL stock under the Base Case scenario is 42.6 USD. Compared to the current market price of 28.02 USD, Omnicell Inc is Undervalued by 34%.
Valuation Backtest
Omnicell Inc
Run backtest to discover the historical profit from buying and selling OMCL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Omnicell Inc
Current Assets | 927.6m |
Cash & Short-Term Investments | 490.5m |
Receivables | 252m |
Other Current Assets | 185.1m |
Non-Current Assets | 1.3B |
Long-Term Investments | 43m |
PP&E | 133.6m |
Intangibles | 1B |
Other Non-Current Assets | 109.1m |
Current Liabilities | 367.8m |
Accounts Payable | 45m |
Accrued Liabilities | 188.3m |
Other Current Liabilities | 134.5m |
Non-Current Liabilities | 670.1m |
Long-Term Debt | 569.7m |
Other Non-Current Liabilities | 100.5m |
Earnings Waterfall
Omnicell Inc
Revenue
|
1.1B
USD
|
Cost of Revenue
|
-647.2m
USD
|
Gross Profit
|
499.9m
USD
|
Operating Expenses
|
-519.3m
USD
|
Operating Income
|
-19.3m
USD
|
Other Expenses
|
-1m
USD
|
Net Income
|
-20.4m
USD
|
Free Cash Flow Analysis
Omnicell Inc
OMCL Profitability Score
Profitability Due Diligence
Omnicell Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Omnicell Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
OMCL Solvency Score
Solvency Due Diligence
Omnicell Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Score
Omnicell Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OMCL Price Targets Summary
Omnicell Inc
According to Wall Street analysts, the average 1-year price target for OMCL is 35.19 USD with a low forecast of 26.26 USD and a high forecast of 42 USD.
Ownership
OMCL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
OMCL Price
Omnicell Inc
Average Annual Return | 7.67% |
Standard Deviation of Annual Returns | 56.75% |
Max Drawdown | -86% |
Market Capitalization | 1.3B USD |
Shares Outstanding | 45 923 500 |
Percentage of Shares Shorted | 7.32% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.
Contact
IPO
Employees
Officers
The intrinsic value of one OMCL stock under the Base Case scenario is 42.6 USD.
Compared to the current market price of 28.02 USD, Omnicell Inc is Undervalued by 34%.